Penn Mutual Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
WA
HWAM
SAM
YIH
SFWA
IWA
PFSRSONJ
CUAMC
Penn Mutual Asset Management's PHAT Position: Q2 2026 in Review
Penn Mutual Asset Management held its Phathom Pharmaceuticals (PHAT) position steady in Q2 2026 at 62,802 shares worth $681K. The position accounts for 3.5% of the portfolio, ranked #5.
Penn Mutual Asset Management first reported a position in PHAT in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.27M in Q1 2021. 16 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.
- Penn Mutual Asset Management held 62,802 shares of Phathom Pharmaceuticals worth $681K as of Q2 2026.
- Penn Mutual Asset Management left its Phathom Pharmaceuticals share count unchanged in Q2 2026.
- Phathom Pharmaceuticals made up 3.5% of Penn Mutual Asset Management's portfolio in Q2 2026, its #5 holding.
- Penn Mutual Asset Management first reported a position in Phathom Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
- Penn Mutual Asset Management's Phathom Pharmaceuticals position peaked at $3.27M in Q1 2021.
- 16 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.
Based on Penn Mutual Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.